Bioscribe
PrivateLast Round
Series A
May 1, 2025
Total Funding Raised
$31.5M
Company Overview
Bioscribe is a boutique life science communications consultancy that provides integrated public relations, media strategy, and corporate communications services for companies in the biotechnology and life sciences sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioscribe Comparables
Compare Bioscribe with similar companies based on industry and business-model similarity.
No public comparables are available for Bioscribe. Request access to learn about comparables coverage.
Request accessBioscribe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2025 | ||||
| Seed | Jan 9, 2020 |
Bioscribe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anzu Partners | Series A, Seed |
| Wilson Sonsini Goodrich & Rosati | Seed |
| Seed Healthcare | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Monthly visitors increased 336% MoM.
- Jul 5, 2025
Monthly visitors grew 64% MoM, reaching 360.
Bioscribe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bioscribe's valuation, stock price, and market status.
Is Bioscribe a public or private company?
Bioscribe is a private company.
What is the current stock price of Bioscribe?
Bioscribe is a private company with no public stock price. Caplight tracks Bioscribe's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Bioscribe worth (valuation)?
Valuation information for Bioscribe is not publicly available.
Can I buy Bioscribe stock?
Bioscribe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bioscribe's last funding round?
Bioscribe's most recent funding round was Series A on May 1, 2025.
Who are the main investors in Bioscribe?
Key investors in Bioscribe include Anzu Partners.
Will Bioscribe IPO soon?
No public IPO plans have been announced for Bioscribe.
How can I track Bioscribe secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioscribe's secondary market activity and sign up for updates.